Modification of narrow ridges for implant placement

Not Applicable

• Conditions: Health Condition 1: K082- Atrophy of edentulous alveolar ridge

• Registration Number: CTRI/2023/08/056265
• Lead Sponsor: GOKILA VANI S

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Physically and mentally healthy patient

-Patients who will be willing and able to comply with the study related procedures.

-Periodontally healthy patient with periodontal probing depth <= 3mm and good oral hygiene.

-Patient having favourable and stable occlusal relationship and natural roots adjacent to the implant site.

-Edentulous sites in maxilla and mandible must be free from infection.

-At least 1-3 teeth missing.

-Having a crestal width of atleast 3mm and an 8mm apico-coronal height from major anatomical structures.

Exclusion Criteria

-History of smoking, chewing tobacco, drug or alcohol abuse, para functional habits.

-History of radiotherapy in the head and neck region for malignancies, bisphosphonate therapy.

-Systemically unhealthy subjects.

-Subjects with acute oral and gingival diseases.

-Pregnancy and lactating mothers.

-Subjects with a history of allergy.

-Unwillingness to sign consent form and review for all follow-up periods.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Alveolar ridge width measurement in all three groups <br/ ><br>2.Implant stability quotient <br/ ><br>3.TorqueTimepoint: 1. For alveolar ridge width, the timepoints are, before & after implant placement in comparator group and before (Pre-op) and after (post-op) ridge expansion in intervention groups <br/ ><br>2. For implant stability quotient, the time points are at the time of implant placement, 3rd month, 6th month <br/ ><br>3.For torque, the time point is at the time of implant placement

Secondary Outcome Measures

Name	Time	Method
1.Pain <br/ ><br>Timepoint: 1.For pain, the timepoints are at the time of surgery,1st week, 2nd week, 4th week after surgery <br/ ><br>;2. Redness & swellingTimepoint: 2.For redness & swelling, the time points are 1st week, 2nd week,4th week after surgery <br/ ><br> <br/ ><br>;3. Soft tissue thicknessTimepoint: 3.For soft tissue thickness, the time points are at the time of surgery, 4th week, 3rd month, 6th month after surgery <br/ ><br>;4. IL-1β & TNFα (if feasible)Timepoint: 4.For IL-1β & TNFα, the timepoints are before prothesis & 2 weeks after prothesis( if feasible)